Ticker ARWR – Arrowhead Pharma – sales, description, marketcap – Tickerday.com

ARWR

Arrowhead Pharma

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 4.45B; Volume: 208.11K; AvgVol 3m: 1.41M; Beta: 1.63;

Cost estimate:

P/E: –; EPS: -0.24; EPS growth quarter/prev quarter: -165.00%;

EPS growth this year: 205.90%; EPS growth past 5 years: 20.60%;

EPS ttm: -0.24;

P/S: 39.20; P/B: 9.59; P/Cashflow: 16.89; P/FCF: ;

Sales: 123.65M; Sales growth quarter/prev quarter: -35.80%; Sales growth past 5 years: 295.20%;

Profitability:

Gross Margin: ; Profit Margin: -19.70%; Operating Margin: -27.00%;

ROA – return on assets: -4.80%; ROE – return on equity: -5.60%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 3.70%; Insider Transactions:-6.34%;

Institutional Ownership: 67.80%; Institutional Transactions: 3.82%;

Data update: 07/10/2020.